Exascale Labs Holdings Inc. (XLAB) Cash Flow Statement
Where XLAB’s cash came from and went, FY2025
June 30, 2025 · U.S. dollars- Cash from operations
- −$1.0M
- Capital expenditures
- $2,138 0.0% of revenue
- Free cash flow
- −$1.0M −14.4% margin
- Returned to shareholders
- —
- Change in cash
- $3.3M cash at year-end $4.2M
Drawn to scale: where the cash came from and how it was used. Hover for values.
XLAB operating cash flow, capex and free cash flow
XLAB cash flow trends, FY2024–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | −$560,909FY2024 | −$1.0MFY2025 | — | |
| Capital expenditures | $27,806FY2024 | $2,138FY2025 | −92.3%/yr | |
| Free cash flow | −$588,715FY2024 | −$1.0MFY2025 | — | |
| Free cash flow margin | −44.6%FY2024 | −14.4%FY2025 | +30.2 pts | |
| Stock-based compensation | $21,104FY2024 | $153,266FY2025 | +626.2%/yr | |
| Capex / revenue | 2.1%FY2024 | 0.0%FY2025 | −2.1 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
XLAB cash flow by activity
XLAB net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
XLAB cash flow statement
| FY2025 | FY2024 | |
|---|---|---|
| Operating activities | ||
| Net income | −$7.7M | −$5.0M |
| Depreciation & amortization | $6,234 | $4,110 |
| Stock-based compensation | $153,266 | $21,104 |
| Change in working capital | $1.9M | $1.3M |
| Other non-cash items | $4.6M | $3.1M |
| Cash from operating activities | −$1.0M | −$560,909 |
| Investing activities | ||
| Capital expenditures | −$2,138 | −$27,806 |
| Financing activities | ||
| Shares issued | $0 | $0 |
| Other financing | $4.3M | $1.3M |
| Cash from financing activities | $4.3M | $1.3M |
| Summary | ||
| Net change in cash | $3.3M | $696,285 |
| Cash at end of period | $4.2M | $969,626 |
| Free cash flow | −$1.0M | −$588,715 |
| Free cash flow margin | −14.4% | −44.6% |
| Capex / revenue | 0.0% | 2.1% |
| Mar '26 | Jun '25 | Mar '25 | |
|---|---|---|---|
| Operating activities | |||
| Net income | −$2.6M | −$1.5M | −$1.5M |
| Depreciation & amortization | $1,565 | $1,601 | $1,601 |
| Stock-based compensation | $0 | $0 | $101,000 |
| Change in working capital | $1.6M | $327,921 | −$207,055 |
| Other non-cash items | $495,433 | $898,769 | $890,523 |
| Cash from operating activities | −$573,830 | −$252,839 | −$750,990 |
| Investing activities | |||
| Capital expenditures | $0 | $0 | $0 |
| Financing activities | |||
| Shares issued | $0 | $0 | $0 |
| Other financing | −$45,000 | $0 | $1.8M |
| Cash from financing activities | −$45,000 | $0 | $1.8M |
| Summary | |||
| Net change in cash | −$12,078 | −$252,839 | $1.0M |
| Cash at end of period | $984,830 | $4.2M | $4.5M |
| Free cash flow | −$573,830 | −$252,839 | −$750,990 |
| Free cash flow margin | −15.3% | −10.0% | −40.3% |
| Capex / revenue | 0.0% | 0.0% | 0.0% |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
XLAB cash generation
In fiscal 2025 (ended June 30, 2025), Exascale Labs generated -$1.0 million of cash from operations and spent $0.0 million on capital expenditures, leaving free cash flow of -$1.0 million, −14.4% of revenue. Cash and equivalents rose by $3.3 million over the year.
Related: XLAB income statement, XLAB balance sheet. See the XLAB stock overview for the latest quote and news.
XLAB cash flow FAQ
What is Exascale Labs's free cash flow?
Exascale Labs's free cash flow was -$1.0 million in fiscal 2025: -$1.0 million of operating cash flow minus $0.0 million of capital expenditures It was -$0.6 million a year earlier..
How much cash does Exascale Labs generate from operations?
Exascale Labs generated -$1.0 million of cash from operating activities in fiscal 2025.
How much does Exascale Labs spend on capital expenditures?
Exascale Labs spent $0.0 million on capital expenditures in fiscal 2025, 0.0% of revenue, compared with $0.0 million the year before.